Hemostatic device developer Z-Medica this week received a majority investment from private equity firm Linden Capital Partners as the company looks to continue expanding the availability of its QuikClot hemostatic products. The investment places Linden Capital alongside current shareholders DW Healthcare Partners, who invested in the company in 2012, according to a statement from CEO Stephen Fanning. […]
Hemostatic device developer Z-Medica said today it won FDA de novo clearance for its QuickClot Control+, now indicated for temporary control of internal organ space bleeding for patients displaying Class III or Class IV bleeding. The Wallingford, Conn.-based company touted its QuickClot Control+ as the 1st and only non-absorbable hemostatic dressing with clearance for internal organ […]
Hemostatic device developer Z-Medica said today it inked a 3 year, $2.7 million deal to supply the New York City police department with QuikClot belt trauma kits. The QuikClot belt trauma kit contains the company’s QuikClot combat gauze, a tourniquet, compression bandage and gloves for controlling bleeding in emergency situations, the Wallingford, Conn.-based company said. “Our […]
Connecticut-based Z-Medical announced this month that it acquired the Novacol resorbable hemostatic product line from rival TAUREON, headquartered in The Netherlands.
TAUREON said that it hopes to focus more on its core businesses, giving over the Novacol line to Z-Medica and its vast distribution network. The companies did not disclose the terms of the deal.
Z-Medica said it named Stephen Fanning, the former CEO of Solta Medical, to be its new chief executive.
Wallingford, Conn.-based Z-Medica is developing blood clotting technologies it calls QuikClot.
Z-Medica Corp.’s blood clotting products are now available in the Netherlands.
The Wallingford, Conn.-based medical device maker signed a distribution deal with Utrecht-based Stöpler Instrumenten & Apparaten B.V for its QuikClot line of hemostatic agents.
Z-Medica Corp. signed an exclusive deal with Romed for sales and distribution of its QuikClot line of hemostatic agents in Belgium.
The contract is the Wallingford, Conn.-based medical device maker’s third international distribution agreement and second in the European Union. In addition to Belgium, Romed operates in Luxemburg and the Netherlands, where it’s based.
Z-Medica Corp. signed an exclusive distribution deal with the Helsinki, Finland-based medical device distributor Fenno Medical Oy.
The Wallingford, Conn.-based hemostatic agent maker said the exclusive deal includes its QuikClot-based products combat gauze, emergency dressing, interventional hemostatic bandage and trauma pad.
Combat gauze, a QuikClot-impregnated wound dressing, is the only product used by all U.S. military forces for treating hemorrhages, according to the company.
Z-Medica Corp. signed an exclusive distribution deal with Japanese electronic patient monitoring device maker Nihon-Kohden.
The contract is the Wallingford, Conn.-based medical device maker’s first international distribution agreement and grants Nihon-Kohden the exclusive right to distribute Z-Medica’s QuikClot line of hemostatic agents throughout Japan.
Z-Medica Corp. pledged to donate $25,000 to the Ohio alma mater of its co-founder to help veterans defray the cost of tuition.
The Wallingford, Conn.-based medical device maker established the "QuikClot Grant," named for its blood-clotting agent, in support of Marietta College’s Yellow Ribbon Program, which gives veterans the chance to attend the college on full scholarships. The program covers costs that aren’t paid for by GI Bill benefits.